boron neutron capture therapy bnct 10b delivered selectively tumour cells nuclide forms radiation 4he2 7li3 neutron capture today research focused development variety boron compounds aimed bnct compounds thoroughly analysed preclinical tests regarding basic characteristics binding subcellular distribution enable accurate estimations factors 121ylmethoxy synthesized laboratories human colon carcinoma cells used vitro model boron compound showed remarkable intracellular accumulation times higher boron content culture medium cultured cells removed extensive washes approximately half boron taken remained cells NUMBER days compound toxic boron concentrations NUMBER micrograms intracellular distribution boron compound investigated subcellular fractionation experiments low ph treatments possible binds intracellular molecules membranes connected organelles cytoplasm inside outer cell membrane possibility compound somewhat lipophilic properties embedded membranes thermal neutron irradiations carried brookhaven medical research reactor bmrr survival level NUMBER thermal neutrons NUMBER times effective cell inactivation thermal neutrons monte carlo calculations gave mean value specific energy dose NUMBER gy total physical dose irradiation cells neutron fluence NUMBER x NUMBER NUMBER gy factor survival level NUMBER comparing irradiation thermal neutrons NUMBER factor comparing neutron irradiations cells irradiation cells NUMBER results encouraging vivo tests tissue distributions tumour uptake carried high let dose modifying dac NUMBER NUMBER NUMBER amino propyl NUMBER dicarba closo dodecaboran NUMBER propanediol ls 174t NUMBER NUMBER dac NUMBER dac NUMBER dac NUMBER 10b dependent dac NUMBER containing dose modifying dac NUMBER dose modifying dac NUMBER 60co gamma b g n cm2